Meeting Overview - The meeting was held on July 30, 2025, with a total of 639 shareholders and representatives present, representing 4,047,500 shares, which is 0.9172% of the total shares [1][2] - A combination of on-site and online voting was utilized, with 633 shareholders participating online [2] Voting Results - The proposals were approved with significant majority votes, including: - 104,630,331 shares in favor, accounting for 96.3525% of the valid votes [2] - 104,607,355 shares in favor, accounting for 96.3314% of the valid votes [3] - 104,617,617 shares in favor, accounting for 96.3408% of the valid votes [3] - 107,580,343 shares in favor, with 102,900 shares abstaining [3] - 107,613,743 shares in favor, with 115,300 shares abstaining [4] - 107,572,143 shares in favor, with 148,000 shares abstaining [5] - 107,765,743 shares in favor, with 115,100 shares abstaining [6] - 107,773,143 shares in favor, with 120,200 shares abstaining [7] Legal Opinion - The legal opinion confirmed that the meeting's procedures, qualifications of the convenor and attendees, and voting processes complied with relevant laws and regulations, ensuring the validity of the voting results [8]
创新医疗: 2025年第二次临时股东会决议公告